Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting ...

Stifel has initiated Compass Pathways (NASDAQ:CMPS) with a buy rating saying that stakeholders are starting to agree there is ...

Who is Bryan Johnson, the tech CEO who spent millions on anti-ageing venture - The entrepreneur has recently revealed what he ...

Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.

As researchers and governments consider the therapeutic uses of psychedelics, Scott Marshall stands ready to supply them.

Childhood psychiatrists insist the drugs, for attention-deficit/hyperactivity disorder (ADHD) and depression, are nonaddictive and proven safe and say they are more concerned about young Americans ...

Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.

The ARTfactory’s Actors Theatre will bring Every Brilliant Thing to the stage in an intimate, thought-provoking performance ...

Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

Roosevelt Day, though the president who guided the country out of the Great Depression and through most of World War ...

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity ... That status goes to Johnson & Johnson's Spravato (esketamine), which was approved in March ...